Quick Takeaways
- Brent Warner has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,730,635.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Brent Warner
- Location
- San Diego, CA
- Summary
- The estimated net worth of Brent Warner is at least $1,730,635 dollars as of 04 Mar 2024. Brent Warner is the President, Gene Therapy of Poseida Therapeutics, Inc. and owns shares of Poseida Therapeutics, Inc. stock worth about $1.73M.
- Signature
- /s/ Harry J.Leonhardt, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Brent Warner and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Poseida Therapeutics, Inc. ($1,730,635).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Brent Warner
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PSTX | Poseida Therapeutics, Inc. | President, Gene Therapy | $1,730,635 | 01 Mar 2024 |
Insider Transactions Reported by Brent Warner:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.